Back to search results

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Abroad (travel likely)RecruitingPHASE4

Conditions

Digestive System Neuroendocrine Tumor G1 · Digestive System Neuroendocrine Tumor G2 · Metastatic Digestive System Neuroendocrine Neoplasm · Metastatic Malignant Neoplasm in the Liver · Pancreatic Neuroendocrine Tumor G1 · Pancreatic Neuroendocrine Tumor G2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Vanderbilt-Ingram Service for Timely Access) · cip@vumc.org · 800-811-8480
    Contact: Principal Investigator (Kamran Idrees, MD)
Study leads

  • Kamran Idrees, MD

    Principal Investigator

    Vanderbilt University/Ingram Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)